Multiplexed Diagnostics Market

20 May

Sample

Multiplexed Diagnostics Market Poised to Grow at a CAGR of 19.3% by 2024

  • By admin

  • January, 1970

Infinium Global Research has added a new report on Multiplexed Diagnostics Market. The report presents analysis of global as well as regional markets of multiplexed diagnostics Market over the period of 2016 to 2024.

Multiplexed diagnostic are used in biological samples that can detect multiple analytes in a single screening process. Multiplexed assays are used in detection of cancer, functional biomolecules (DNA & RNA) and infectious disease. Moreover, multiplexed diagnostic assays have advantages, such as time efficiency and highly precise accuracy that can analyze defects and mutations in any functional biomolecules (DNA, RNA, and protein).

 

Increase incidence of chronic diseases is one of the major reason that is driving the growth of the multiplexed diagnostic market. Multiplexed diagnostics helps in early diagnosis that minimizes the risk associated with chronic disease/infection and helps in proper treatment management. With increase concern for early disease detection, the demand for the multiplexed diagnostic market will increase. Meanwhile, lack of trained professionals and less awareness regarding multiplexed diagnostic especially in developing and underdeveloped regions hinders the growth of the market. Increase awareness about the multiplexed diagnostic in untapped regions can create growth opportunities for the market in near future

 

North America accounts for 49.54% of market share in multiplexed diagnostic market in 2017 and is expected to dominate throughout the forecast period, 2018-2024. U.S drives the North America region on account of rising prevalence of cardiac diseases and cancer and availability of better healthcare infrastructure in this region. Asia pacific region is expected to grow at the highest CAGR of 22.5% during the forecast period.

Key Development- Mercodia had launched the AKURIO Islet hormone multiplex assay in collaboration with Quansys Bioscience in October 2017. This assay was designed to assess four different hormones in pancreatic study that include glucagon, insulin, C-peptide, and proinsulin. AKURIO Islet hormone multiplex assay provides high data accuracy with reliable speed.

 

Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global multiplexed diagnostics Market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.

 

Get 15% discount for early purchase of global multiplexed diagnostics Market report by clicking the following link, Use code IGRD15 to request the discount in the given form

https://www.infiniumglobalresearch.com/reports/request-discount/1345

 

The recent report identified that dominated the global multiplexed diagnostics Market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the multiplexed diagnostics Market worldwide.


The report segments the global multiplexed diagnostics market on the basis of Method, Application and End User.

 

Global Multiplexed Diagnostics Market by Method

·         Very High Density Multiplexed Assays

·         High Density Multiplexed Assays

·         Mid Density Multiplexed Assays

·         Low Density Multiplexed Assays

·         Others

 

Global Multiplexed Diagnostics Market by Application

·         Infectious Diseases

·         Oncology

·         Cardiology

·         Autoimmune Diseases

·         Allergic Diseases

·         Others

 

Global Multiplexed Diagnostics Market by End User

·         Academic Research

·         Hospitals

·         Diagnostic Labs

·         Pharma Companies

·         Clinical Research

 

Companies Profiled in the Report

·         Agilent Technologies

·         Abbott Laboratories

·         Thermo Fisher Scientific, Inc.

·         Siemens Healthineers

·         Bio-Rad Laboratories, Inc.

·         F. Hoffmann-La Roche Ltd

·         BioMérieux SA

·         Luminex Corporation

·          Illumina, Inc

·         Others

 

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.